Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Euronext Paris  >  Sanofi    SAN   FR0000120578

SANOFI (SAN)

Real-time Quote. Real-time Tradegate - 02/12 04:02:19 pm
69.434 EUR   +3.22%
02/10 Sovereign funds' selling could hit $700 billion of European stock..
02/10DJSanofi's Diabetes Approach Stumbles
02/09DJSanofi Is Forced to End Latest Diabetes Effort
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Sanofi
Engages in the research, production and distribution of pharmaceutical products

Sanofi engages in the research, production and distribution of pharmaceutical products.

It operates through the following segments: Pharmaceuticals, Human Vaccines, Animal Health, and Others.

The Pharmaceuticals segment includes research, development, production and sales activities relating to pharmaceutical products, including prescription, consumer health care, and generic products.

This segment also includes equity affiliates and joint ventures with pharmaceutical business activities.

The Human Vaccines segment includes research, development, production and marketing of vaccines.

The Animal Health segment comprises the research, development, production and marketing activities for Merial, which offers a range of medicines and vaccines for a wide variety of animal species.

The Others segment includes all activities that do not qualify as reportable segments under IFRS 8 “Operating Segments”; it also includes the effects of retained commitments in respect of divested businesses.

The company was founded in 1994 and is headquartered in Paris, France.

Number of employees : 113 496 persons.
Sales per Businesses
20132014Delta
EUR (in Million)%EUR (in Million)%
Pharmaceuticals27,25082.7%27,72082.1% +1.7%
Vaccines3,71611.3%3,97411.8% +6.49%
Animal Health1,9856%2,0766.1% +4.38%
Sales per Regions
20132014Delta
EUR (in Million)%EUR (in Million)%
Other Countries11,44134.7%11,45333.9% +0.1%
United States10,43331.7%11,33933.6% +7.99%
Europe7,93324.1%7,93223.5% -0.01%
France2,5717.8%2,4747.3% -3.92%
North America573.001.7%572.001.7% -0.17%
Managers
NameAgeSinceTitle
Olivier Brandicourt MD, PhD602015Chief Executive Officer
Serge Weinberg652009Chairman
Jérôme Contamine592009Chief Financial Officer & EVP-Finance
Elias E. Zerhouni, MD652011President-Global Research & Development
Robert Castaigne, PhD702000Independent Director
Jean-René Fourtou772004Independent Director
Claudie Haigneré MD, PhD592008Independent Director
Uwe Bicker MD, PhD712008Independent Director
Carole Piwnica582010Independent Director
Suet-Fern Lee582011Independent Director
Shareholders
NameEquities%
L'Oréal SA 118,444,357 9.07%
Norges Bank Investment Management 29,478,282 2.26%
Dodge & Cox 26,957,852 2.06%
The Vanguard Group, Inc. 22,572,687 1.73%
Berkshire Hathaway, Inc. (Investment Management) 22,169,930 1.70%
Plan d'Epargne Entreprise Sanofi Synthelabo 17,075,788 1.31%
Amundi Asset Management SA (Investment Management) 16,777,524 1.29%
BlackRock Fund Advisors 14,775,317 1.13%
Lyxor International Asset Management SAS 13,904,075 1.06%
THEAM SAS 12,695,781 0.97%
Holdings
NameEquities%Valuation
Regeneron Pharmaceuticals Inc (REGN) 23,192,50822.7%12,590,516,818 USD
Alnylam Pharmaceuticals, Inc. (ALNY) 10,256,63312.1%965,559,431 USD
Aventis Pharma Limited (AVPH) 13,909,58760.4%916,232,424 USD
Zentiva SA (ROSCD) 312,341,64974.9%153,522,167 USD
Nichi-iko Pharmaceutical Co., Ltd. (4541) 2,846,0004.69%68,618,426 USD
Myokardia Inc (MYOK) 3,218,89911.9%47,189,059 USD
Merrimack Pharmaceuticals Inc (MACK) 3,074,7182.66%24,290,272 USD
Immune Design Corp (IMDZ) 917,4294.55%18,421,974 USD
SCYNEXIS Inc (SCYX) 1,677,05712.1%10,414,524 USD
Proteome Sciences plc (PRM) 38,0000.017%8,821 USD
Sector
Healthcare
Pharmaceuticals & Medical Research
 Pharmaceuticals
  Pharmaceuticals
   Pharmaceuticals - NEC
Advertisement
Sector Pharmaceuticals
Growth (Revenue) Profitability
JOHNSON & JOHNSON
ROCHE HOLDING LTD..
NOVARTIS AG
PFIZER INC.
MERCK & CO., INC.
ALLERGAN PLC
NOVO NORDISK A/S
BRISTOL-MYERS SQU..
SANOFI
GLAXOSMITHKLINE P..
BAYER AG
ELI LILLY AND CO
ASTRAZENECA PLC
TEVA PHARMACEUTIC..
-
ABBOTT LABORATORI..
TAKEDA PHARMACEUT..
ASTELLAS PHARMA I..
SHIRE PLC
VALEANT PHARMACEU..
MYLAN NV
Sector Pharmaceuticals
Sanofi : Connections
Pres héSam
Sanofi-Aventis Europe SAS
Sanofi-Aventis Participations SA
Aventis Foundation
AXA Asia SAS
Academie des Sports
Piasa Holding
i2O Water Ltd.
Sanofi Pasteur Holding SA
Sanofi Pasteur Holding & Merial Ltd.
École Normale Supérieure
La Campus Condorcet
Sanofi-Aventis U.S. LLC
Académie des Sciences et Technologies
Ruprecht-Karls-Universität Heidelberg
Council on Foreign Relations, Inc.
Elevance Renewable Sciences, Inc.
Research!America
King Abdullah University of Science & Technology
Paris Bar Association
Warp Drive Bio LLC
National Heritage Board
Académie Nationale de Médecine
Montres CORUM Sàrl
National Academy of Engineering
Fondations René Lacoste
Institute of Medicine
Fondation Lacoste
The Johns Hopkins University
Académie des Technologies
Financières SASA
Academie de l'air et de l'espace
Financière Piasa
Philipps University of Marburg
Weinberg Capital Partners SAS
Alliance Automotive Group SAS
Bordeaux University Foundation
Naxos UK Ltd.
Madrigall SA
International Federation of Pharmaceutical Manufacturers A
Big Red, Inc.
RecyCoal Ltd.
Asian Civilisations Museum
Select Music & Video Distribution Ltd.
Piasa SA
New York State Bar Association
Pharmaceutical Research & Manufacturers of America
NAXOS Capital Managers SARL
Rickmers Trust Management Pte Ltd.
Stamford Law Corp.
Universcience.fr
Singapore Bar
Nanyang Technological University
The Children's Aid Society, Inc.
Stamford Corporate Services Pte Ltd.
Fondation C.Génial
AXA Group Solutions
L'Oréal Corporate Foundation
World Justice Project
Fondation de France
International Bar Association
Company contact information
54 rue la Boétie
FR-75008 Paris
France

Phone : +33 (0)1 53 77 40 00
Fax : +33 (0)1 53 77 44 63
Internet : http://www.sanofi.com
Markets and indexes
- PEA / SRD eligible : YES / YES
- Euronext Paris
- Compartiment A
- CAC 40 / CAC All Shares, CAC All-Tradable, CAC Large 60, Euronext 100, EuroStoxx 50, FTSE Eurotop 100, Low Carbon 100 Europe, Stoxx Europe 50, Stoxx France 50, Stoxx Global 200
Stock Exchange Codes
- ISIN Code :  FR0000120578
- Bloomberg Code :  SAN:FP
- Reuters Code :  SASY.PA
- Datastream Code :  F:SQ@F
© 2016 People , Fundamentals and Ownership    © 2016 Cofisem